Monthly Archives: January 2021

China CDC

Posted on by

China CDC
http://www.chinacdc.cn/en/
No new digest content identified.

National Health Commission of the People’s Republic of China [to 9 Jan 2021]
http://en.nhc.gov.cn/
News
Jan 9: Daily briefing on novel coronavirus cases in China
On Jan 8, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 33 new cases of confirmed infections.

Hebei strengthens curbs as confirmed cases rise to 127
2021-01-08
Shijiazhuang, capital of Hebei province, has been put under a lockdown after the city reported the highest daily COVID-19 case numbers since the outbreak occurred over the past weekend.

China pledges safety, effectiveness as vaccination to be carried out nationwide
2021-01-05

National Medical Products Administration [to 9 Jan 2021]
http://english.nmpa.gov.cn/news.html
News
Free virus vaccinations for overseas travel
2021-01-07
Shanghai residents who need to travel overseas for personal reasons will be able to make reservations for COVID-19 vaccine inoculation beginning on Thursday, the municipal government announced on Jan 6.

Chinese mainland reports 52 new locally transmitted COVID-19 cases
2021-01-07
China’s National Health Commission said on Jan 7 that it received reports of 63 newly confirmed COVID-19 cases on the Chinese mainland on Jan 6, of which 52 were locally transmitted and 11 were imported.

Announcements

Posted on by

Announcements

 

Paul G. Allen Frontiers Group [to 9 Jan 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 9 Jan 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
BARDA News
No new digest content identified.

 

BMGF – Gates Foundation [to 9 Jan 2021]
http://www.gatesfoundation.org/Media-Center/Press-Releases
Press Releases and Statements
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 9 Jan 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 9 Jan 2021]
https://carb-x.org/
News
No new digest content identified.

 

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 9 Jan 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
An Informed Choice/Consent/Right-to-Refuse Imperative :: Statement on Immunization Involving COVID-19 Vaccines Under Emergency Use Authorization/Listing [EUA/L]
1 January 2021 The GE2P2 Global Foundation’s Center for Vaccine Ethics and Policy has developed a statement that argues that immunization involving COVID-19 vaccines available under emergency use mechanisms or expanded access/compassionate use triggers an imperative to assure that individuals receive the information required to support free exercise of meaningful informed choice/consent, with a right to refuse such vaccination for any reason or no reason. The full statement is available here: http://www.ge2p2.org/the-informed-choice/consent/right-to-refuse-imperative

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 9 Jan 2021]
http://cepi.net/
Latest News
No new digest content identified.

 

EDCTP [to 9 Jan 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

 

Emory Vaccine Center [to 9 Jan 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Medicines Agency [to 9 Jan 2021]
http://www.ema.europa.eu/ema/
News & Press Releases
News: Extra dose from vials of Comirnaty COVID-19 vaccine
Last updated: 08/01/2021
[See COVID above for detail]

 

 

News: EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU (updated)
Last updated: 06/01/2021
[See COVID above for detail]

 

European Vaccine Initiative [to 9 Jan 2021]
http://www.euvaccine.eu/
Latest News
Website not responding at inquiry

 

FDA [to 9 Jan 2021]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements /Selected Details
January 8, 2021 – Coronavirus (COVID-19) Update: January 8, 2021
:: The FDA alerted clinical laboratory staff and health care providers that genetic variants of SARS-CoV-2 may lead to false negative results with molecular tests for SARS-CoV-2. The Letter to Clinical Laboratory Staff and Health Care Providers includes important information about potential false negative results with molecular tests, including:
. Details on the effect of genetic variants on test performance.
. Recommendations for clinical laboratory staff and health care providers.
. Actions the FDA has taken.
. Instructions for reporting problems with a test.
:: This week, the FDA posted a new webpage, Moderna COVID-19 Vaccine Frequently Asked Questions. Questions cover specifics, such as what data did the FDA review when deciding whether to authorize the vaccine for emergency use, how well the vaccine prevents COVID-19, and more.

January 8, 2021 – FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff
The U.S. Food and Drug Administration is alerting clinical laboratory staff and health care providers that the FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests, and that false negative results can occur with any molecular test for the detection of SARS-CoV-2 if a mutation occurs in the part of the virus’s genome assessed by that test…

January 5, 2021 – Coronavirus (COVID-19) Update: January 5, 2021
:: Today, the FDA posted a new webpage on the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) highlighting authorities that are intended to enhance the FDA’s ability to identify, prevent, and mitigate possible drug shortages by, among other things, enhancing the FDA’s visibility into drug supply chains…

 

FDA – COVID-19 Vaccines [to 9 Jan 2021]
www.fda.gov/covid19vaccines
News and Updates; Upcoming Events
FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines
Following the Authorized Dosing Schedules for COVID-19 Vaccines
01/04/2021
[See COVID above for detail]

 

Fondation Merieux [to 9 Jan 2021]
http://www.fondation-merieux.org/
News, Events
Press Releases
No new digest content identified.

 

Gavi [to 9 Jan 2021]
https://www.gavi.org/
News releases
No new digest content identified.

 

GHIT Fund [to 9 Jan 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
Press Releases
No new digest content identified.

 

Global Fund [to 9 Jan 2021]
https://www.theglobalfund.org/en/news/
News
Strategic Review 2020 of the Global Fund now available
07 January 2021
The Strategic Review 2020 (SR2020) of the Global Fund and its related documents are now available. As with the SR2015 and SR2017, it was commissioned by the Technical Evaluation Reference Group (TERG). The three main objectives of SR2020 were:
[1] To assess the outcomes and impact of Global Fund investments against the goals and objectives of the 2017–2022 Strategy at its mid-term.
[2] To assess operationalization and implementation of the current Strategy at its mid-term.
[3] To provide an evidence-informed rationale for integrating lessons learned during the first half of the 2017–2022 Strategy, and how to position the Global Fund within the global field of health development organizations in its post-2022 strategic cycle.
Download the Strategic Review 2020 and all its related materials. Learn more about the TERG and its role at the Global Fund.

 

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 9 Jan 2021]
https://www.glopid-r.org/news/
News
No new digest content identified.

 

Hilleman Laboratories [to 9 Jan 2021]
http://www.hillemanlabs.org/
No new digest content identified.

 

Human Vaccines Project [to 9 Jan 2021]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
No new digest content identified.

 

IAVI [to 9 Jan 2021]
https://www.iavi.org/newsroom
PRESS RELEASES/FEATURES
No new digest content identified.

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.

 

IFRC [to 9 Jan 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.

 

Institut Pasteur [to 9 Jan 2021]
https://www.pasteur.fr/en/press-area
Press documents
No new digest content identified.

 

IRC International Rescue Committee [to 9 Jan 2021]
http://www.rescue.org/press-release-index
Media highlights [Selected]
Press Release
As thousands more fleeing conflict in Ethiopia arrive in Eastern Sudan, the IRC scales up emergency response to protect women and children
January 6, 2021

 

IVAC [to 9 Jan 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
No new digest content identified.

 

IVI [to 9 Jan 2021]
http://www.ivi.int/
Selected IVI News, Announcements, Events
Cellid, IVI exchange ‘COVID-19 Vaccine Research Service Contract’
IVI to analyze samples from Phase 1/2a trials of Cellid’s COVID-19 vaccine to evaluate immunogenicity
January 5, 2021

2020 Year in Review
2020 was an unprecedented year in global health. A novel virus spread to all corners of the world, devastating people’s lives, economies, and ways of life, and the scientific community responded with agility and partnership that will inspire vaccine research and development for years to come. We’re grateful to our global collaborators, supporters, and friends for working with us to advance IVI’s mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health—a mission that feels more urgent than ever and will continue to drive our work in the new year.

 

JEE Alliance [to 9 Jan 2021]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

Johns Hopkins Center for Health Security [to 9 Jan 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 9 Jan 2021]
http://www.msf.org/
Latest [Selected Announcements]
Yellow fever
Fractioning doses of yellow fever vaccine can help save more lives
Press Release 8 Jan 2021

Lebanon
Overlapping crises in Lebanon increase needs and worsen access to …
Project Update 8 Jan 2021

Mali
Patient dies after an MSF ambulance is violently detained in …
Press Release 7 Jan 2021

Palestine
“For one year no one came here” to provide medical care in the W…
Project Update 5 Jan 2021

Central African Republic
MSF provides care in post-election attacks in Bangassou, CAR
Project Update 4 Jan 2021

 

National Vaccine Program Office – U.S. HHS [to 9 Jan 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
No new digest content identified.

 

NIH [to 9 Jan 2021]
http://www.nih.gov/news-events/news-releases
News Releases
Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
January 5, 2021 — The Phase 2/3 clinical trial will evaluate experimental antibodies BRII-196 and BRII-198.

 

PATH [to 9 Jan 2021]
https://www.path.org/media-center/
Press Release
PATH condemns violent insurgency in Washington, DC
January 7, 2021 by PATH

PATH supports partners to use environmental surveillance to monitor the presence of COVID-19
January 5, 2021 by PATH
Complementing national COVID-19 surveillance efforts in countries with limited diagnostic capacity to test and trace with expanded data from the environmental surveillance of sewage

 

Sabin Vaccine Institute [to 9 Jan 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 9 Jan 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
8 January 2021
First-ever Jamaica transgender strategy looks beyond health

6 January 2021
Hope from Tiraspol

5 January 2021
Y+ Global launches COVID-19 fund to support young people living with HIV

 

UNICEF [to 9 Jan 2021]
https://www.unicef.org/media/press-releases
Selected Press releases, Statements
No new digest content identified.

 

Unitaid [to 9 Jan 2021]
https://unitaid.org/
Featured News
No new digest content identified.

 

Vaccination Acceptance Research Network (VARN) [to 9 Jan 2021]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 9 Jan 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
No new digest content identified.

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 9 Jan 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
No new digest content identified.

 

Wellcome Trust [to 9 Jan 2021]
https://wellcome.ac.uk/news
News
Wellcome appoints new research programmes director 
Cheryl Moore, who is currently the President and Chief Operating Officer of the New York Genome Center, is to become Wellcome’s new Director, Research Programmes.

 

The Wistar Institute [to 9 Jan 2021]
https://www.wistar.org/news/press-releases
Press Releases
Jan. 7, 2021
Wistar Scientists Target an Alternative Fuel Source of Cancer Cells as a Therapeutic Approach for Breast Cancer
New small molecule inhibitor impairs cancer growth in preclinical models by depriving malignant cells of a critical nutrient source.

 

WFPHA: World Federation of Public Health Associations [to 9 Jan 2021]
https://www.wfpha.org/
Latest News
COVID-19 Immunization and Mitigating Vaccine Hesitancy
Jan 6, 2021
… The WFPHA Immunization Taskforce fears that the lack of a coordinated response to growing vaccine hesitancy will further exacerbate the morbidity and mortality rates of the pandemic. In particular, there is concern that the uncontrolled spread of misinformation will disproportionately harm the most at-risk, vulnerable communities. As global COVID-19 immunization begins, health organizations and governments must be equipped to promote trust in the vaccines being distributed and must work alongside healthcare providers who are responsible for delivery. Therefore, the WFPHA International Immunization Policy Task Force in its Statement on COVID-19 Immunization and Mitigating Vaccine Hesitancy, recommends:
1. National authorities, NGOs and health organizations should publicly express support for subnational
and/or community-led initiatives that address vaccine hesitancy to help sustain local COVID-
19 immunization efforts.
2. The international community should acknowledge that life course immunization is a key
component of universal health coverage and a necessary preventative measure that can save millions
of lives.
3. Public health officials and organizations should express their concerns about the lack of investment
and infrastructure needed to target public health messages to at-risk populations and recommend
investing in public health promotion and literacy as a preventative measure.
4. Knowledge translation research efforts be strengthened to enhance communication between
public health professionals, policymakers, and the general public with the goal of establishing a
common agenda.
5. Governments should maintain transparency about vaccine funding and development to ensure
that the general public understands how this intervention best serves public health interests.

 

World Economic Forum [to 9 Jan 2021]
https://agenda.weforum.org/news/
Media
Cities Are Key to India’s Post-Pandemic Growth, Says Report
News 07 Jan 2021
· The World Economic Forum releases a new report, Indian Cities in the Post-Pandemic World, with recommendations from 14 global urban experts to translate lessons learned from the pandemic into a new urban reforms agenda
· Insights compiled through extensive interviews span seven thematic areas: planning, housing, transport, environment, public health, gender and vulnerable populations
· Read the full report here

 

World Organisation for Animal Health (OIE) [to 9 Jan 2021]
https://www.oie.int/en/for-the-media/press-releases/2020/
No new digest content identified.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 9 Jan 2021]
https://alliancerm.org/
Press Releases
No new digest content identified.

 

BIO [to 9 Jan 2021]
https://www.bio.org/press-releases
Press Releases
BIO’s Dr. Michelle McMurry-Heath Responds to “Unconscionable” Attacks on U.S. Capitol
January 7, 2021
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today’s violence at the United States Capitol: “Today we watched in horror as angry and unruly mobs attacked…

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 9 Jan 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 9 Jan 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.

 

IFPMA [to 9 Jan 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
No new digest content identified.

 

PhRMA [to 9 Jan 2021]
http://www.phrma.org/
Selected Press Releases, Statements
New research shows hotspots of inequity relate to increased COVID-19 hospitalizations
January 8, 2021
As part of PhRMA’s continuing work to address health inequities, we are partnering with researchers to study hotspots of COVID-19 and chronic disease inequities in New York state. Reports this summer show that boroughs in New York City with the lowest per-person income and lowest number of employer establishments had the highest COVID-19 mortality rates.

Journal Watch

Posted on by

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Exception From Informed Consent: How IRB Reviewers Assess Community Consultation and Public Disclosure

Posted on by

AJOB Empirical Bioethics
Volume 12, 2020 Issue 1
https://www.tandfonline.com/toc/uabr21/current

 

Article
Exception From Informed Consent: How IRB Reviewers Assess Community Consultation and Public Disclosure
Makini Chisolm-Straker, Denise Nassisi, Mohamud R. Daya, Jennifer N.B. Cook, Ilene F. Wilets, Cindy Clesca & Lynne D. Richardson
Pages: 24-32
Published online: 29 Sep 2020

Legacies of the Holocaust in Health Care

Posted on by

AMA Journal of Ethics
Volume 23, Number 1: E1-81 Jan 2021
https://journalofethics.ama-assn.org/issue/legacies-holocaust-health-care

 

Legacies of the Holocaust in Health Care
Health professionals’ involvement in atrocities of the Holocaust has influenced bioethics in critical ways. From abortion to xeno-transplantation, deliberation on almost every ethics topic in health care today—genetics, informed consent, public health, military and civilian health policy and practice, death and dying, human subjects research, and refugee care—is influenced by Nazi medical crimes. This theme issue is devoted to orienting and reorienting contemporary bioethics to legacies of this tragic history.

“Prevention” and Human Gene Editing Governance

Posted on by

AMA Journal of Ethics
Volume 23, Number 1: E1-81 Jan 2021
https://journalofethics.ama-assn.org/issue/legacies-holocaust-health-care

 

State of the Art and Science
“Prevention” and Human Gene Editing Governance
Eric T. Juengst, PhD
AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
Abstract
The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. In part, this is because prevention can mean 3 different things, which are often conflated. Phenotypic prevention involves modifying the expression of pathogenic DNA variants to forestall their clinical effects in at-risk patients. Genotypic prevention involves controlling transmission of pathogenic variants between generations to avoid the birth of affected offspring. Preventive strengthening seeks to improve normal human traits to resist disease. These distinctions have been neglected in human gene editing governance discussions and are clarified in this article.

Attaining 95-95-95 through Implementation Science: 15 Years of Insights and Best Practices from the Walter Reed Army Institute of Research’s Implementation of the U.S. President’s Emergency Plan for AIDS Relief

Posted on by

American Journal of Tropical Medicine and Hygiene
Volume 104, Issue 1, January 2021
http://www.ajtmh.org/content/journals/14761645/104/1

 

Perspective Piece
Attaining 95-95-95 through Implementation Science: 15 Years of Insights and Best Practices from the Walter Reed Army Institute of Research’s Implementation of the U.S. President’s Emergency Plan for AIDS Relief
Elizabeth H. Lee, Kavitha Ganesan, Samoel A. Khamadi, Stanley C. Meribe, Dorothy Njeru, Yakubu Adamu, Fred Magala, Trevor A. Crowell, Eniko Akom, Patricia Agaba, Priyanka Desai, Tiffany Hamm, Deydre Teyhen, Julie A. Ake, Christina S. Polyak, Douglas Shaffer, Fredrick Sawe and Patrick W. Hickey
Pages: 12–25
https://doi.org/10.4269/ajtmh.20-0541

Fighting COVID-19 at the Expense of Malaria in Africa: The Consequences and Policy Options

Posted on by

American Journal of Tropical Medicine and Hygiene
Volume 104, Issue 1, January 2021
http://www.ajtmh.org/content/journals/14761645/104/1

Fighting COVID-19 at the Expense of Malaria in Africa: The Consequences and Policy Options
Abdullahi Tunde Aborode, Kenneth Bitrus David, Olivier Uwishema, Agbendeh Lubem Nathaniel, Jegede Oluwatoyin Imisioluwa, Sherifdeen Bamidele Onigbinde and Fozia Farooq

 

Pages: 26–29
https://doi.org/10.4269/ajtmh.20-1181

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection (5 January, 2021)

Posted on by

BMJ Global Health
January 2021 – Volume 6 – 1
https://gh.bmj.com/content/6/1

 

Analysis
The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection (5 January, 2021)
Caitlin M Pley, Anna L McNaughton, Philippa C Matthews, José Lourenço

Selfie consents, remote rapport, and Zoom debriefings: collecting qualitative data amid a pandemic in four resource-constrained settings (8 January, 2021)

Posted on by

BMJ Global Health
January 2021 – Volume 6 – 1
https://gh.bmj.com/content/6/1

 

Practice
Selfie consents, remote rapport, and Zoom debriefings: collecting qualitative data amid a pandemic in four resource-constrained settings (8 January, 2021)
In-person interactions have traditionally been the gold standard for qualitative data collection. The COVID-19 pandemic required researchers to consider if remote data collection can meet research objectives, while retaining the same level of data quality and participant protections. We use four case studies from the Philippines, Zambia, India and Uganda to assess the challenges and opportunities of remote data collection during COVID-19. We present lessons learned that may inform practice in similar settings, as well as reflections for the field of qualitative inquiry in the post-COVID-19 era.
Mark Donald C Reñosa, Chanda Mwamba, Ankita Meghani, Nora S West, Shreya Hariyani, William Ddaaki, Anjali Sharma, Laura K Beres, Shannon McMahon

Vaccination strategies for measles control and elimination: time to strengthen local initiatives

Posted on by

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 9 Jan 2021)

 

Vaccination strategies for measles control and elimination: time to strengthen local initiatives
Through a combination of strong routine immunization (RI), strategic supplemental immunization activities (SIA) and robust surveillance, numerous countries have been able to approach or achieve measles elimina…
Authors: F. T. Cutts, M. J. Ferrari, L. K. Krause, A. J. Tatem and J. F. Mosser
Content type: Opinion
5 January 2021

A feasibility trial of parent HPV vaccine reminders and phone-based motivational interviewing

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles

 

Research
A feasibility trial of parent HPV vaccine reminders and phone-based motivational interviewing
We assessed the feasibility and acceptability of a sequential approach of parent-targeted HPV vaccine reminders and phone-based Motivation Interviewing (MI).
Authors: Stephanie A. S. Staras, Eric Richardson, Lisa J. Merlo, Jiang Bian, Lindsay A. Thompson, Janice L. Krieger, Matthew J. Gurka, Ashley H. Sanders and Elizabeth A. Shenkman
Citation: BMC Public Health 2021 21:109
Content type: Research article
Published on: 9 January 2021

Vaccination concerns, beliefs and practices among Ukrainian migrants in Poland: a qualitative study

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles

 

Vaccination concerns, beliefs and practices among Ukrainian migrants in Poland: a qualitative study
Ukrainians numbering approximately 1.2 million are the largest migrant group in Poland. Data on vaccination coverage among migrants are not collected in EU, including Poland. Therefore, this qualitative study …
Authors: Maria Ganczak, Klaudia Bielecki, Marzena Drozd-Dąbrowska, Katarzyna Topczewska, Daniel Biesiada, Agnieszka Molas-Biesiada, Paulina Dubiel and Dermot Gorman
Citation: BMC Public Health 2021 21:93
Content type: Research article
Published on: 7 January 2021

Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles

 

Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science
The global spread of coronavirus disease 2019 (COVID-19) has been mirrored by diffusion of misinformation and conspiracy theories about its origins (such as 5G cellular networks) and the motivations of prevent…
Authors: Jon Agley and Yunyu Xiao
Citation: BMC Public Health 2021 21:89
Content type: Research article
Published on: 7 January 2021

Knowledge, attitudes and practices on influenza vaccination during pregnancy in Quito, Ecuador

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles

 

Knowledge, attitudes and practices on influenza vaccination during pregnancy in Quito, Ecuador
Vaccination is the most effective way to prevent infection and severe outcomes caused by influenza viruses in pregnant women and their children. In Ecuador, the coverage of seasonal influenza vaccination in pr…
Authors: Carlos E. Erazo, Carlos V. Erazo, Mario J. Grijalva and Ana L. Moncayo
Citation: BMC Public Health 2021 21:72
Content type: Research article
Published on: 7 January 2021

An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles

 

An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
Inactivated Polio Vaccine (IPV) campaign was conducted in February 2019 in Karachi where needle-free injectors were introduced for the administration of the fractional dose of IPV (fIPV) on a large scale. This…
Authors: Umar Farooq Bullo, Jaishri Mehraj, Syed Musa Raza, Shumaila Rasool, Noreen Naz Ansari, Ahmed Ali Shaikh, Zamir Ali Phul, Sohail Ahmed Memon, Rehan Iqbal Baloch, Zahoor Ahmed Baloch and Shoukat Ali Chandio
Citation: BMC Public Health 2021 21:44
Content type: Research article
Published on: 6 January 2021

Ensuring equitable access to vaccines for refugees and migrants during the COVID-19 pandemic

Posted on by

Bulletin of the World Health Organization
Volume 99, Number 1, January 2021, 1-76
https://www.who.int/bulletin/volumes/99/1/en/

 

Ensuring equitable access to vaccines for refugees and migrants during the COVID-19 pandemic
— Jozef Bartovic, Siddharta Sankar Datta, Santino Severoni & Veronika D’Anna
http://dx.doi.org/10.2471/BLT.20.267690
…To address these issues, national vaccination policies need to adopt innovative measures. Immunization doses missed as a result of COVID-19 pandemic containment measures should be offered as quickly as possible to refugees and migrants. Mobile vaccination clinics, combined health-care services (such as antenatal care and vaccination programmes) and mass vaccination campaigns should be considered to address existing immunity gaps. All efforts must consider delivery of immunization services in hard-to-reach settings and to hard-to-reach population groups…
…Effective measures to address barriers to immunization for refugees and migrants must include strengthening the capacity of health systems and primary health-care providers; setting up or expanding immunization information systems to monitor vaccination coverage; developing training and awareness of health-care providers; establishing health literacy education programmes; and ensuring national immunization programmes are resilient to humanitarian or health crises.3

Informed Consent for Genetic and Genomic Research

Posted on by

Current Protocols in Human Genetics
Volume 108, Issue 1 December 2020
https://currentprotocols.onlinelibrary.wiley.com/toc/19348258/current

 

OVERVIEW
Informed Consent for Genetic and Genomic Research
Jeffrey R. Botkin jeffrey.botkin@hsc.utah.edu
First Published:17 November 2020
Abstract
Genetic research often utilizes or generates information that is potentially sensitive to individuals, families, or communities. For these reasons, genetic research may warrant additional scrutiny from investigators and governmental regulators, compared to other types of biomedical research. The informed consent process should address the range of social and psychological issues that may arise in genetic research. This article addresses a number of these issues, including recruitment of participants, disclosure of results, psychological impact of results, insurance and employment discrimination, community engagement, consent for tissue banking, and intellectual property issues. Points of consideration are offered to assist in the development of protocols and consent processes in light of contemporary debates on a number of these issues.

Nature and history of the CIOMS International Ethical Guidelines and implications for local implementation: A perspective from East Africa

Posted on by

Developing World Bioethics
Volume 20, Issue 4 Pages: 173-230 December 2020
https://onlinelibrary.wiley.com/toc/14718847/current

 

ORIGINAL ARTICLES
Nature and history of the CIOMS International Ethical Guidelines and implications for local implementation: A perspective from East Africa
John Barugahare, Paul Kutyabami
Pages: 175-183
First Published: 23 October 2019

Context matters: On the road to responsible biosafety technologies in synthetic biology

Posted on by

EMBO Reports
Volume 22 Issue 1 7 January 2021
https://www.embopress.org/toc/14693178/current

 

Science & Society 28 December 2020 Open Access
Context matters: On the road to responsible biosafety technologies in synthetic biology
Amalia Kallergi, Enrique Asin‐Garcia, Vitor AP Martins dos Santos, Laurens Landeweerd
Biosafety is a major challenge for developing for synthetic organisms. An early focus on application and their context could assist with the design of appropriate genetic safeguards.

Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries

Posted on by

Epidemiology and Infection
Volume 149 – 2021
https://www.cambridge.org/core/journals/epidemiology-and-infection/latest-issue

 

Short Paper
Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries
C. Wei, C. C. Lee, T. C. Hsu, W. T. Hsu, C. C. Chan, S. C. Chen, C. J. Chen
Published online by Cambridge University Press: 28 December 2020, e1

From impact evaluation to decision-analysis: assessing the extent and quality of evidence on ‘value for money’ in health impact evaluations in low- and middle-income countries [version 1; peer review: awaiting peer review]

Posted on by

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 9 Jan 2021]

 

Research Article metrics AWAITING PEER REVIEW
From impact evaluation to decision-analysis: assessing the extent and quality of evidence on ‘value for money’ in health impact evaluations in low- and middle-income countries [version 1; peer review: awaiting peer review]
Noemi Kreif, Andrew J. Mirelman, James Love-Koh, Sangjun Kim, Rodrigo Moreno-Serra, Paul Revill, Mark Sculpher, Marc Suhrcke
Peer Reviewers: Invited
Funders: National Institute for Health Research, Gates Foundation
PUBLISHED 07 Jan 2021

An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets

Posted on by

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 9 Jan 2021]

 

An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets
During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online “immuno-analytics” resource that…
Authors: Daniel Ward, Matthew Higgins, Jody E. Phelan, Martin L. Hibberd, Susana Campino and Taane G. Clark
Citation: Genome Medicine 2021 13:4
Content type: Database
Published on: 7 January 2021

Sociocultural, behavioural and political factors shaping the COVID-19 pandemic: the need for a biocultural approach to understanding pandemics and (re)emerging pathogens

Posted on by

Global Public Health
Volume 16, 2021 Issue 1
http://www.tandfonline.com/toc/rgph20/current

 

Article
Sociocultural, behavioural and political factors shaping the COVID-19 pandemic: the need for a biocultural approach to understanding pandemics and (re)emerging pathogens
Anna Friedler
Pages: 17-35
Published online: 06 Oct 2020

Regional cooperation is essential to combatting health emergencies in the Global South

Posted on by

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 9 Jan 2021]

 

Regional cooperation is essential to combatting health emergencies in the Global South
Since COVID-19 was first discovered, it exploded into a pandemic resulting in devastating effects on human lives and a global recession. While there have been discussions that COVID-19 will accelerate the ‘end…
Authors: Ana B. Amaya and Philippe De Lombaerde
Citation: Globalization and Health 2021 17:9
Content type: Commentary
Published on: 9 January 2021

Disability inclusion in humanitarian action

Posted on by

Humanitarian Exchange Magazine
Number 78, October 2020
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Disability inclusion in humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange, co-edited with Sherin Alsheikh Ahmed from Islamic Relief Worldwide, is disability inclusion in humanitarian action. Persons with disabilities are not only disproportionately impacted by conflicts, disasters and other emergencies, but also face barriers to accessing humanitarian assistance. At the same time, global commitments and standards and the IASC Guidelines on the inclusion of persons with disabilities in humanitarian action all emphasise how persons with disabilities are also active agents of change. Disability and age-focused organisations have led on testing and demonstrating how inclusion can be done better. Yet despite this progress, challenges to effective inclusion remain.

As Kirstin Lange notes in the lead article, chief among these challenges is humanitarian agencies’ lack of engagement with organisations of persons with disabilities. Simione Bula, Elizabeth Morgan and Teresa Thomson look at disability inclusion in humanitarian response in the Pacific, and Kathy Al Jubeh and Alradi Abdalla argue for a ‘participation revolution’, building on learning from the gender movement. Tchaurea Fleury and Sulayman AbdulMumuni Ujah outline how the Bridge Article 11 training initiative is encouraging constructive exchange between humanitarian and disability actors. The lack of good, disaggregated data is highlighted by Sarah Collinson; Frances Hill, Jim Cranshaw and Carys Hughes emphasise the need for training resources in local languages and accessible formats; and Sophie Van Eetvelt and colleagues report on a review of the evidence on inclusion of people with disabilities and older people.

Rebecca Molyneux and co-authors analyse the findings of a review of a DFID programme in north-east Nigeria, while Carolin Funke highlights the importance of strategic partnerships between disability-focused organisations, drawing on her research in Cox’s Bazar. Sherin Alsheikh Ahmed describes Islamic Relief Worldwide’s approach to mainstreaming protection and inclusion, while Pauline Thivillier and Valentina Shafina outline IRC’s Client Responsive Programming. The edition ends with reflections by Mirela Turcanu and Yves Ngunzi Kahashi on CAFOD’s SADI approach.

Accessing the syndemic of COVID-19 and malaria intervention in Africa

Posted on by

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 9 Jan 2021]

 

Accessing the syndemic of COVID-19 and malaria intervention in Africa
The pandemic of the coronavirus disease 2019 (COVID-19) has caused substantial disruptions to health services in the low and middle-income countries with a high burden of other diseases, such as malaria in sub…
Authors: Benyun Shi, Jinxin Zheng, Shang Xia, Shan Lin, Xinyi Wang, Yang Liu, Xiao-Nong Zhou and Jiming Liu
Citation: Infectious Diseases of Poverty 2021 10:5
Content type: Research Article
Published on: 7 January 2021

Efforts to mitigate the economic impact of the COVID-19 pandemic: potential entry points for neglected tropical diseases

Posted on by

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 9 Jan 2021]

 

Efforts to mitigate the economic impact of the COVID-19 pandemic: potential entry points for neglected tropical diseases
The damage inflicted by the coronavirus diseases 2019 (COVID-19) pandemic upon humanity is and will continue to be considerable. Unprecedented progress made in global health over the past 20 years has reverted…
Authors: John P. Ehrenberg, Jürg Utzinger, Gilberto Fontes, Eliana Maria Mauricio da Rocha, Nieves Ehrenberg, Xiao-Nong Zhou and Peter Steinmann
Citation: Infectious Diseases of Poverty 2021 10:2
Content type: Scoping Review
Published on: 4 January 2021

Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website

Posted on by

International Journal of Infectious Diseases
January 2021 Volume 102 p1-590
https://www.ijidonline.com/current

 

Coronavirus (COVID-19) Collection
Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website
Hakan Erdem, Daniel R. Lucey
Published online: October 29, 2020

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular DiseaseA Randomized Clinical Trial

Posted on by

JAMA
January 5, 2021, Vol 325, No. 1, Pages 9-96
https://jamanetwork.com/journals/jama/currentissue

 

Original Investigation
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular DiseaseA Randomized Clinical Trial
Orly Vardeny, PharmD, MS; KyungMann Kim, PhD; Jacob A. Udell, MD, MPH; et al.
JAMA. 2021;325(1):39-49. doi:10.1001/jama.2020.23649
This randomized clinical trial compares the effect of high-dose vs standard-dose influenza vaccine on all-cause mortality and hospitalizations due to cardiovascular or pulmonary causes in patients with high-risk cardiovascular disease.

How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign

Posted on by

JAMA
January 5, 2021, Vol 325, No. 1, Pages 9-96
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign
Nicole Lurie, MD, MSPH; Bettina Experton, MD, MPH
free access has active quiz
JAMA. 2021;325(1):21-22. doi:10.1001/jama.2020.22720
This Viewpoint proposes that Medicare claims data could inform the rollout of a COVID-19 vaccination program in the US, including notifying beneficiaries of their risk and prioritization and supporting efforts to allocate the vaccine and monitor its uptake, immunogenicity, and safety.

Young Adult Human Papillomavirus and Influenza Vaccine Coverage: A Comparison Across College Enrollment Status

Posted on by

Journal of Community Health
Volume 46, issue 1, February 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-1

 

Articles
Young Adult Human Papillomavirus and Influenza Vaccine Coverage: A Comparison Across College Enrollment Status
Authors: Kara Mathewson, Maria Sundaram, Robert A. Bednarczyk,
Content type: Original Paper
Published: 15 May 2020
Pages: 13 – 21

Implication of a High Risk for Type 2 Vaccine-Derived Poliovirus Emergence and Transmission After the Switch From Trivalent to Bivalent Oral Poliovirus Vaccine

Posted on by

Journal of Infectious Diseases
Volume 223, Issue 1, 1 January 2021
https://academic.oup.com/jid/issue/223/1

 

VIRUSES
Implication of a High Risk for Type 2 Vaccine-Derived Poliovirus Emergence and Transmission After the Switch From Trivalent to Bivalent Oral Poliovirus Vaccine
Dongmei Yan, Dongyan Wang, Yong Zhang, Xiaolei Li, Haishu Tang …
The Journal of Infectious Diseases, Volume 223, Issue 1, 1 January 2021, Pages 113–118, https://doi.org/10.1093/infdis/jiaa386
The switch from trivalent to bivalent oral poliovirus vaccine can provide high-level immunity against type 1 and 3 poliovirus but not against type 2, indicating a high risk of type 2 vaccine-derived poliovirus emergence and transmission.

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania

Posted on by

Journal of Infectious Diseases
Volume 223, Issue 1, 1 January 2021
https://academic.oup.com/jid/issue/223/1

 

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
Ananda S Bandyopadhyay, Chris Gast, Elizabeth B Brickley, Ricardo Rüttimann, Ralf Clemens …
The Journal of Infectious Diseases, Volume 223, Issue 1, 1 January 2021, Pages 119–127, https://doi.org/10.1093/infdis/jiaa390

Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)

Posted on by

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 9 Jan 2021]

 

Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
Medicines are important health interventions and their appropriate use could improve health outcomes. Throughout the globe, pharmacists play a very important role to improve the use of medicines. Though high-i…
Authors: Zaheer-Ud-Din Babar
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:6
Content type: Commentary
Published on: 6 January 2021

Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey

Posted on by

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 9 Jan 2021]

 

Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey
Spontaneous reporting of adverse drug reactions (ADRs) is a method of monitoring the safety of drugs and is the basic strategy for the post-marketing surveillance of the suspected drugs. Despite its importance…
Authors: Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi and Tayyaba Akram
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:5
Content type: Research
Published on: 4 January 2021

Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic: the great forgotten

Posted on by

Journal of Travel Medicine
Volume 28, Issue 1, January 2021
https://academic.oup.com/jtm/issue

 

Perspectives
Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic: the great forgotten
Marta Tilli, MD, Piero Olliaro, PhD, Federico Gobbi, PhD, Zeno Bisoffi, PhD, Alessandro Bartoloni, MD …
Journal of Travel Medicine, Volume 28, Issue 1, January 2021, taaa179, https://doi.org/10.1093/jtm/taaa179
In non-endemic countries, the access to healthcare for migrants and other patients with NTDs may be hampered by new barriers linked to the COVID-19 pandemic. Low awareness of health care professionals on the opportunistic potential of some NTDs may lead to unfavorable outcome of COVID-19 patients treated with immunomodulatory drugs.